It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-013.mrc:232157170:11435
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-013.mrc:232157170:11435?format=raw

LEADER: 11435cam a22003734a 4500
001 6277252
005 20221122014557.0
008 060519t20072007paua b 001 0 eng
010 $a 2006048136
015 $aGBA759085$2bnb
016 7 $a013785361$2Uk
020 $a0323039618
020 $a9780323039611
035 $a(OCoLC)ocm69645842
035 $a(OCoLC)69645842
035 $a(NNC)6277252
035 $a6277252
040 $aDLC$cDLC$dBTCTA$dBAKER$dUKM$dC#P$dOrLoB-B
042 $apcc
050 00 $aRC685.H8$bC585 2007
082 00 $a616.1/32$222
245 00 $aComprehensive hypertension /$c[edited by] Gregory Y.H. Lip, John E. Hall.
260 $aPhiladelphia, Pa. :$bMosby Elsevier,$c[2007], ©2007.
300 $axxiii, 1222 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gSect. 1.$tEpidemiology /$rEdited by John F. Hall, Gregory Y. H. Lip and Paul K. Whelton -- $g1.$tA short history of the study of hypertension /$rD. Gareth Beevers and J. Ian S. Robertson -- $g2.$tBlood pressure in westernized and isolated populations /$rLydia A. Bazzano, Jiang He and Paul K. Whelton -- $g3.$tRegional differences in blood pressure in developed countries /$rPatricia M. Kearney and Ivan J. Perry -- $g4.$tEarly-life influences on blood pressure /$rDebbie A. Lawlor and George Davey Smith -- $g5.$tBlood pressure and the risks of cardiovascular disease and stroke /$rDonald M. Lloyd-Jones and Philip Greenland -- $g6.$tLifestyle and blood pressure /$rLydia A. L. Bazzano and Jiang He -- $g7.$tDietary fats and blood pressure /$rTrevor A. Mori, Valerie Burke and Lawrence J. Beilin -- $g8.$tEffects of dietary patterns /$rLawrence J. Appel -- $gSect. 2.$tPathogenesis /$rEdited by Joey P. Granger and Leong L. Ng -- $g9.$tRenovascular hypertension : pathophysiology and evaluation of renal function /$rSabas I. Gomez, John A. Haas and J. Carlos Romero -- $g10.$tLeft ventricular physiology and pathophysiology in hypertension /$rGeorge W. Booz -- $g11.$tHemodynamics of hypertension /$rJoseph L. Izzo, Jr. -- $g12.$tThe arterial system in human hypertension /$rDaniel A. Duprez and Jay N. Cohn -- $g13.$tResistance vessels in hypertension /$rMichel E. Safar and Bernard I. Levy -- $g14.$tThe endothelium in hypertension : assessment and clinical aspects of micro- and macrovascular function /$rAndrew D. Blann -- $g15.$tVascular remodeling and rarefaction in hypertension /$rMatthew A. Boegehold -- $g16.$tThe RhoA/Rho-kinase signaling pathway in vascular smooth muscle contraction : biochemistry, physiology, and pharmacology /$rCleber E. Teixeira and R. Clinton Webb -- $g17.$tMatrix metalloproteinases and the extracellular matrix /$rMuzahir H. Tayeujec and Gregory Y. H. Lip -- $g18.$tCell membranes (blood cell and platelet membranes in human essential hypertension) /$rDieter Rosskopf -- $g19.$tArterial and venous function in hypertension /$rKeshari M. Thakali, James J. Galligan, Gregory D. Fink and Stephanie W. Watts -- $g20.$tSodium pumps /$rPeter A. Doris -- $g21.$tPlatelet and coagulation abnormalities /$rGeorge I. Varughese and Gregory Y. H. Lip -- $g22.$tRole of cytokines and inflammation in hypertension /$rMichael J. Ryan -- $g23.$tRole of the kidney in hypertension /$rJoey P. Granger and John E. Hall -- $g24.$tThe baroreflex in the pathogenesis of hypertension /$rThomas E. Lohmeier and Heather A. Drummond -- $g25.$tCentral nervous system control of blood pressure /$rCarrie A. Northcott and Joseph R. Haywood -- $g26.$tAldosterone and other steroids /$rJohn W. Funder -- $g27.$tThe Renin-Angiotensin system in the pathophysiology of essential hypertension /$rRobert M. Carey -- $g28.$tThe endothelin system /$rErnesto L. Schiffrin -- $g29.$tNitric oxide /$rMarcela Herrera, Pablo A. Ortiz, Guillermo B. Silva and Jeffrey L. Garvin -- $g30.$tReactive oxygen species, oxidative stress, and vascular biology in hypertens on /$rF. Tabet and Rhian M. Touyz -- $g31.$tNatriuretic peptides /$rJacob George and Allan D. Struthers -- $g32.$tOther peptide and related systems including substance P, calcitonin gene-related peptide, and serotonin /$rAdrian G. Stanley -- $g33.$tMultiple roles of eicosanoids in blood pressure regulation /$rJohn Quilley and John C. McGiff -- $g34.$tRole of sex steroids in hypertension /$rJane F. Reckelhoff, Licy L. Yanes, Radu Iliescu, Lourdes A. Fortepiani and Julio C. Sartori-Valinotti -- $g35.$tGenetic approaches to hypertension : relevance to human hypertension /$rCarlo Giansante and Nicola Fiotti -- $g36.$tMonogenic forms of human hypertension /$rBeverley Burke, Johannie Gungadoo, Ana Carolina B. Marcano, Stephen J. Newhouse, Julian Shiel, Mark J. Caulfield and Patricia B. Munroe -- $g37.$tTherapeutic potential of systemic gene transfer strategy for hypertension and cardiovascular disease /$rShant Der Sarkissian and Mohan K. Raizada -- $g38.$tPathophysiology of obesity-induced hypertension and target organ damage /$rJohn E. Hall, Alexandre A. da Silva, Elizabeth L. Brandon, David E. Stec, Zhekang Ying and Daniel W. Jones -- $g39.$tExercise and hypertension /$rKevin P. Davv ̃and Christopher L. Gentile -- $g40.$tElectrolyte intake and human hypertension /$rVamadevan S. Ajay, Dorairaj Prahhakaran and Kolli Srinath Reddy -- $g41.$tAlcohol intake and blood pressure /$rIan B. Puddev and Lawrence J. Beilin -- $g42.$tPsychosocial stress and hypertension /$rMichael W. Brands and Dexter L. Lee -- $gSect. 3.$tClinical approaches /$rEdited by Ernesto L. Schiffrin and Robert J. MacFadyen -- $g43.$tOverview of assessment and investigation of hypertension : a pragmatic practical approach /$rJudith A. Whitworth -- $g44.$tBlood pressure measurement /$rThomas G. Pickering -- $g45.$tOut-of-office blood pressure monitoring /$rThomas G. Pickering -- $g46.$tCardiologic investigation of the hypertensive patient /$rRobert J. MacFadyen -- $g47.$tThe effects of hypertension on the structure of human resistance vessels /$rEnrico Agabiti Rosei and Damiano Rizzoni -- $g48.$tThe brain in hypertension /$rMartin D. Fotherby, David J. Eveson and Thompson G. Robinson -- $g49.$tKidney disease and hypertension /$rPanteleimon A. Sarafidis ̃and George L. Bakris -- $g50.$tHypertensive heart disease /$rJavier Diez -- $g51.$tThe eye in hypertension /$rTien Yin Wong and Paul Mitchell -- $g52.$tHypertension in children and adolescents /$rJoseph T. Flynn -- $g53.$tHypertension in the elderly /$rStanley S. Franklin -- $g54.$tHypertension in pregnancy /$rJason G. Umans -- $g55.$tInsulin resistance and diabetes in hypertension /$rMaryann N. Mugo, Daniel Link, Craig S. Stump and James R. Sowers -- $g56.$tHypertension in renal failure /$rBranko Braam and Hein A. Koomans -- $g57.$tHypertension in racial and ethnic minorities /$rJohn M. Flack, Samar A. Nasser, Mark Britton, Anna B. Valina-Toth, Vineeta Ahooja and Shannon M. O'Connor -- $g58.$tHyperadrenergic and labile hypertension /$rGuido Grassi and Giuseppe Mancia -- $g59.$tResistant hypertension /$rWilliam J. Elliott -- $g60.$tPerioperative hypertension : preparing the hypertensive patient for anesthesia for surgery /$rPierre Foex -- $g61.$tHypertension in the context of acute myocardial infarction and percutaneous coronary interventions /$rRurni Jaumcally and Gregory Y. H. Lip -- $g62.$tHypertension in patients with concomitant cardiac disorders /$rHung-Fat Tse -- $g63.$tHypertensive urgencies and emergencies /$rEhud Grossman and Franz H. Messerli -- $g64.$tRenovascular hypertension /$rGraham W. Lipkin, Purchimada Uthappa and Jason Moore -- $g65.$tProteinuria /$rChris Isles -- $g66.$tRenin-secreting tumors and other renin-secreting states /$rMichel Azizi, Pierre-Francois Plouin and Laurence Amar ̃-- $g67.$tPrimary hyperaldosteronism and other forms of mineralocorticoid hypertension /$rHari Krishnan Parthasarathy and Thomas M. MacDonald -- $g68.$tGlucocorticoid hypertension /$rSteven Miller and John M. C. Connell -- $g69.$tCushing's syndrome and human glucocorticoid hypertension /$rFernando Eliovich ̃and Cheryl L. Laffer -- $g70.$tOral contraceptives, hormone replacement therapy, and hypertension /$rTalma Rosenthal and Suzanne Oparil -- $g71.$tDrug-induced hypertension /$rEhud Grossman and Franz H. Messerli -- $g72.$tCatecholamines, pheochromocytoma, and hypertension : genomic insights /$rFangwen Rac, Ryan Friese, Gen Wen, Lian Zhang, Yuqing Chen, Madhusudan Das, Kuixing Zhang, Bruce A. Hamilton, Nicholas J. Shork, Laurent Taupenot, Sushil K. Mahata, Michael G. Ziegler and Daniel T. O'Connor -- $g73.$tNonadrenal endocrine hypertension /$rJ. Enrique Silza -- $g74.$tCoarctation of the aorta /$rRichard A. Krasuski and Fetnat Fouad-Tarazi -- $g75.$tHypertension due to central nervous system dysfunction /$rJ. David Spenze -- $g76.$tSleep apnea and hypertension /$rPeter Y. Hahn and Virend K. Somers -- $gSect. 4.$tPharmacologic and nonpharmacologic interventions and treatment guidelines /$rEdited by Daniel W. Jones and Chim C. Lang -- $g77.$tDiuretics /$rJohn Setaro and Marvin Moser --
505 80 $g78.$tBeta blockers in hypertension /$rGurusher S. Panjrath and Franz H. Messerli -- $g79.$tCalcium antagonists /$rStefano Taddei, Lorenzo Ghiadoni, Agostino Virdis and Antonio Salvetti -- $g80.$tAngiotensin-converting enzyme inhibitors /$rAlan H. Gradman and Derren Traub -- $g81.$tAngiotensin II receptor blockers /$rHans R. Brunner -- $g82.$tAlpha adrenoreceptor antagonists /$rHenry L. Elliot -- $g83.$tCentrally acting agents /$rDomenic A. Sica -- $g84.$tVasodilators /$rGordon T. McInnes -- $g85.$tNovel drug treatments for hypertension /$rHenry Krum and Jennifer Martin -- $g86.$tFixed low-dose antihypertensive therapy /$rRyan M. Woodham and Suzanne Oparil -- $g87.$tInteractions between antihypertensive drugs and other medications /$rNigel J. Langford and Anthony Cox -- $g88.$tLipid-lowering therapy /$rIan S. Young and Brona V. Loughrey -- $g89.$tAntithrombotic therapy in hypertension /$rGregory Y. H. Lip -- $g90.$tControl of blood glucose and insulin resistance /$rKathleen Wyne and George L. Bakris -- $g91.$tTarget blood pressure in hypertension treatment : the J-shaped curve controversy /$rN. C. Shah and Chim C. Lang -- $g92.$tAdherence, quality of life, cost-effectiveness, and the role of the pharmacist /$rBarry L. Carter -- $g93.$tNonpharmacologic management of hypertension /$rSaverio Stranges and Francesco P. Cappuccio -- $g94.$tMultidisciplinary management of hypertension and the role of the nurse /$rCheryl R. Dennison and Martha N. Hill -- $g95.$tWorld Health Organization/International Society of Hypertension (WHO/ISH) : hypertension guidelines and statements /$rJudith A. Whitworth -- $g96.$tTreatment guidelines : the United States JNC7 /$rDaniel W. Jones -- $g97.$tThe 2003 guidelines for the management of hypertension of the European Society of hypertension and European Society of cardiology /$rAlberto Zanchetti -- $g98.$tTreatment guidelines : the developing world /$rKolli Srinath Reddy, Nitish Naik and Dorairaj Prabhakaran.
650 0 $aHypertension.$0http://id.loc.gov/authorities/subjects/sh85063723
650 12 $aHypertension.$0https://id.nlm.nih.gov/mesh/D006973
700 1 $aLip, Gregory Y. H.$0http://id.loc.gov/authorities/names/n96116297
700 1 $aHall, John E.$q(John Edward),$d1946-$0http://id.loc.gov/authorities/names/n83056627
852 00 $boff,hsl$hRC685.H8$iC585 2007 Q